Belgin Sever

30PUBLICATIONS
46CO-AUTHORS
Haematological tumoursBiologically active moleculesMolecular targetsReaction engineering (excl. nuclear reactions)Computational chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 26, 2026
Targeting ABL Tyrosine Kinase in Chronic Myeloid Leukemia: Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Thiazolone Derivatives.

|Mar 28, 2026
Design, Synthesis, and Biological Evaluation of <i>N</i>,<i>N</i>-Diphenylaniline-Based Derivatives as Antiproliferative Agents and ABL TK Inhibitors Against CML.

Belgin Sever, Halilibrahim Ciftci

|Jan 28, 2026
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity.

Belgin Sever, Cüneyt Türkeş, Yeliz Demir

|Aug 14, 2025
Design, Synthesis, and Anticancer Evaluation of New Small-Molecule EGFR Inhibitors Targeting NSCLC and Breast Cancer.

Belgin Sever, Masami Otsuka, Mikako Fujita

|Jul 18, 2025
Insights into therapeutic discovery through the Kelch domain structure of Keap1 at ambient temperature.

Merve Yilmaz, Belgin Sever, Yiğit Kutlu

|May 14, 2025
Structural Insights into the Dynamics of Water in SOD1 Catalysis and Drug Interactions.

Ilkin Yapici, Arda Gorkem Tokur, Belgin Sever

Pageof 5

Frequent Collaborators

21 joint publications

Halilibrahim Ciftci

13 joint publications

Mikako Fujita

11 joint publications

Mehlika Dilek Altıntop

8 joint publications

Hasan DeMirci